Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K9/00—Medicinal preparations characterised by special physical form
  • A61K9/0012—Galenical forms characterised by the site of application
  • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/34—Alcohols
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/34—Alcohols
  • A61K8/347—Phenols
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
  • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
  • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/63—Steroids; Derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
  • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
  • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9783—Angiosperms [Magnoliophyta]
  • A61K8/9789—Magnoliopsida [dicotyledons]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin

Definitions

• the invention relates to new cosmetic and/or medicinal compositions which beneficially affect virus-induced infections and inflammations- of the skin and mucosa and promote the regeneration of the dermatoses caused, i.e. the compositions are able to restore the initial conditions of the skin.
• compositions of the invention are special ⁇ ly suitable for the treatment of infections and dermatoses induced by herpes virus.
• the cited patents also confirm that in this field of indication the use of natural substances is becoming popular world-wide, too.
• the present invention is also a representative of this trend of development, and is based on the observation that active ingredient concentrates can be prepared from particular natural substances by a specific process which can be used, alone or in combination, for the production of cosmetic agents or medicinal cosmetics of improved activity. Their activity can be further increased by applying adjuvants or specific formulations.
• the invention relates to compositions of manifold application with viricide, antiinflamma- tory and regenerating activity wherein the concentrations of the ingredients given % by weight are as follows: Glycyrrhizin, preferably in the form of sweet-root extract 0.005-0.4
• Rosemary acid preferably in the form of plant extract 0.005-0.4
• compositions may contain further carriers, additives and auxiliary materials usually applied in the preparation of cosmetic or medicinal compositions, preferably water, propyleneglycol, acrylamide-sodium aerylate copolymer, PEG-7, glycerol cocoate and isooctyl nonanoate, as well as solubilizing agents, lipids, preservatives and fragrance components in hydrogel, lotion-ointment, liquid emulsion, spray, stick or drop formulation.
• auxiliary materials usually applied in the preparation of cosmetic or medicinal compositions, preferably water, propyleneglycol, acrylamide-sodium aerylate copolymer, PEG-7, glycerol cocoate and isooctyl nonanoate, as well as solubilizing agents, lipids, preservatives and fragrance components in hydrogel, lotion-ointment, liquid emulsion, spray, stick or drop formulation.
• rosemary acid (caffeoyl- -hydroxy-dihydrocaffeic acid) , together with quinic acid, chlorogenic acid and caffeic acid, is present in plants of the labiate family (Laminaceae) , mainly in Melissa officinalis, Hyssopus officinalis, Rosmarinus officinalis and Salvia officinalis. Its virostatic, antibacterial and antimycotic potency is reported by I. K. Heimann and . Schultze in the Zeitschrift fur Phythotherapie Sept. 1988, 82-83.
• sweet root (Glycyr- rhiza glabra) extracts are used as sweeteners to improve taste and as expectorants (B. Issekutz: (Drug pres ⁇ cription, Gy ⁇ gyszerrendeles p. 600 Medicina, Budapest, 1979) .
• the regular use of standard preparations may reduce the increased tension of the stomach wall and the inflamination of gastric mucosa (Gizella Verzar Petri: Gy ⁇ gyn ⁇ venyek a gy ⁇ gyaszatban (Medicinal plants in therapy), p. 92, Medicina, Budapest, 1984).
• Russian authors [I. A.
• Glycyr- rhizin the major constituent of sweet root has mineralo- corticoid, antiinflammatory, antiedema and epithelizing (wound healing) properties.
• the volatile oil of thyme (Thymus vulgaris) contains mainly thymol, carvacrol, p-cymol, furthermore linalool, borneol, geraniol and ⁇ - pinene.
• thyme oil Due to its thymol content the thyme oil has viricide effect and inhibits a major part of wound bacteria even at 3000fold dilution (Gizella Verzar Petri: Medicinal plants in therapy, Medicina, Budapest, 1984, p. 74.).
• the ⁇ -bisabolol is one of the major components of camomile (Matricaria chamomilla) . Primarily it has antiinflam atory effect and promotes granulation. The allantoin promotes the skin-regeneration and hydration.
• the collagens which can be found in the skin, also play role in hydration, but based on other mechanism.
• the polydocanol is ingredient of numerous medicinal and cosmetic composition. It has analgetic and local anaesthetic effect.
• An aqeous alcohol (methanol, ethanol, iso- propanol) extract is prepared from the leaves of a plant from Laminaceae family, e.g. rosemary, melilot (Melissa officinalis) , Salvia officinalis and Hyssopus officinalis, etc. After removing the sol ⁇ vent the residue is acidified to pH 2-3 with an inorganic acid, the mixture is extracted with a water immiscible solvent (ether, chloroform, di- chloromethane, ethyl acetate, etc.), the layers are separated and the solvent is removed from the orga ⁇ nic layer yielding a dry extract.
• a water immiscible solvent ether, chloroform, di- chloromethane, ethyl acetate, etc.
• the product is specifically beneficial for symptoms of the mucosa (oral and genital) induced by herpes simplex virus. Applied in the early stage the development of erythema and edema is suppressed and recovery is accelerated. In recurrent cases, applied before the development of symptoms, superinfection is fully inhi- bited. Furthermore, subjective symptoms, such as itching and stretching, are alleviated, and recovery is rapid and traceless. The skin becomes refreshed and hydrated.
• Figure 1 presents the results of the compa- rative study of the preparation of the invention (herpes gel prepared according to procedure 1) and that of the commercial control products, together with the duration of recovery of untreated cases. The following control preparations were tested in the study ( Figure 1 shows the mean values of the results obtained) :
• Medicinal gel and paint formulation containing the extract of 15 % (w/w) Chelidonium herba, 3 % (w/w) Menthae piperita folium, 1 % (w/w) Calendula officinalis, 2 % (w/w) Thy i herba and 2 % (w/w) Millefolii herba, prepared with 50 % (w/w) ethanol.
• Medicinal suspension ointment formulation containing 0.8 % (w/w) of 3-(2-deoxy-D-ribofuranosyl)-5- isopropyluracyl.
• Medicinal alcoholic gel formulation containing 0.2 % (w/w) primicium sulfuricum and 2 % (w/w) lidocain.
• formulations of the preparations according to the invention are listed as follows: in the major part of indications the most advantageous formulation proved to be the rapidly absorbing and penetrating gel form which is easy to handle.
• the formulations specified (1-3) are partly usual gels and partly microemulsions [values in the table are expressed in % by weight (w/w) ] :
• Acrylic acid/Na acrylate copolymer (Hostacerin PN 73) 2.0 1.5 POE(45) hydrogenated ricinol acid triglyceride
• PCL liquid Isooctadecyl isononanoate (PCL liquid) 2.0 0.3
• Thyme- oil 0.02 0.025 0.02 Distilled water ad 100 100 100
• the gels are prepared by dissolving allantoin in the bulk of water, then in some cases (formulations l- 2) also the copolimer, using slow stirring.
• Ointment is also a formulation of choice, see formulations 4 to 6 [values in the table are expressed in % by weight (w/w) ] :
• Ointments are prepared by melting the lipid components and the emulsifier - liquid paraffin, stearin, isooctyl stearate or polyoxyethylene (POE) fatty acid ester, resp. - and heating the mixture to about 70°C. Thereafter the polydocanol is added, and, if desired (formulations 5 and 6) , Irgasan. Allantoin is dissolved in water then the aqueous phase is heated to about 70°C.
• POE polyoxyethylene
• Alcoholic paint, drop or spray are also formulations of choice.
• the composition of formulations 7 to 9 are listed in the following.
• Triclosan (Irgasan OP 300) 0.05 0.1
• the solutions are prepared by solubilizing first the thyme oil, preferably with POE(45) hydrogenated ricinol acid triglyceride. Irgasan is dissolved in alcohol, and allantoin in the bulk of water. The phases prepared in this way are mixed, then, under constant stirring the solution of ⁇ -bisabolol and collagen (formulations 7 and 8) is added to the system, finally the propyleneglycol solution of glycyrrhizin and rosemary acid. Stirring is continued for a couple of minutes after the addition.
• Alcoholic painting composition and aerosol foam or spray composition using an appropriate carrier gas can be also prepared.

Priority Applications (1)

Applications Claiming Priority (2)

Publications (1)

Family

ID=10982077

Family Applications (1)

Country Status (3)

Cited By (13)

Citations (8)

• 1992
  • 1992-06-18 HU HU9202040A patent/HU209370B/hu not_active IP Right Cessation
• 1993
  • 1993-06-17 AU AU43525/93A patent/AU4352593A/en not_active Abandoned
  • 1993-06-17 WO PCT/HU1993/000038 patent/WO1993025209A1/en active Application Filing

Patent Citations (8)

Non-Patent Citations (4)

Also Published As

Similar Documents

Legal Events